泛免疫炎症值对抑郁人群全因和特定原因死亡率的预测价值:基于NHANES与NDI的队列数据分析OA
Predictive value of pan-immune-inflammation value for all-cause and cause-specific mortality in depressed individuals:a cohort study
目的 评估泛免疫炎症值(pan-immune-inflammation value,PIV)对抑郁状态人群中全因和特定原因死亡率的预测价值.方法 本研究为一项前瞻性队列研究,数据来自美国2005-2018年国家健康和营养检查调查(National Health and Nutrition Examination Survey,NHANES)和2005-2019年国家死亡指数(National Death Index,NDI).共纳入了8 567名参与者.参与者按PIV四分位数分组(Q1、Q2、Q3、Q4)或按二分位数分组(low组、high组),采用Cox比例风险模型评估PIV与抑郁人群全因死亡率、心血管死亡率和癌症死亡率的相关性;通过平滑曲线拟合探讨非线性剂量反应关系,经阈值效应分析确定拐点后,以拐点为界,将参与者分为2组,并构建分段回归模型并结合Kaplan-Meier生存曲线探究PIV与节段生存状态之间的关系.亚组分析探讨了PIV与死亡率关联的稳定性.结果 Cox结果显示,较高的PIV水平与全因死亡率(HR=1.05,95%CI:1.04~1.07,P<0.001)、心血管死亡率(HR=1.07,95%CI:1.05~1.10,P<0.001)和癌症死亡率(HR=1.05,95%CI:1.01~1.08,P<0.001)增加显著相关.平滑曲线拟合结果显示,PIV与全因死亡率之间存在U型关系,拐点为80.97(P<0.05).生存分析显示:当PIV>80.97时,与low组相比,high组的全因死亡率(HR=1.29,95%CI:1.12~1.48,P<0.001)升高;与Q1组相比,Q4组的全因死亡率(HR=1.53,95%CI:1.25~1.87,P<0.001)升高.亚组分析结果显示,在女性人群中PIV与全因死亡率(HR=1.08,95%CI:1.05~1.10,P=0.038)和心血管死亡率(HR=1.11,95%CI:1.07~1.16,P=0.031)的关联更强;患有糖尿病以及其他种族(除墨西哥裔美国人、其他西班牙裔、非西班牙裔白人、非西班牙裔黑人之外)人群的PIV与全因死亡率[糖尿病(HR=1.09,95%CI:1.06~1.10,P=0.023)其他种族(HR=1.22,95%CI:1.11~1.35,P=0.032)]和癌症死亡率[糖尿病(HR=1.12,95%CI:1.06~1.18,P=0.006)、其他种族(HR=2.00,95%CI:1.79~2.24,P=0.002)]的关联更强.结论 PIV升高是抑郁状态人群多种死亡结局的独立危险因素.本研究明确PIV作为死亡风险预测生物标志物的潜力,对高危人群早期识别、精准管理及疾病负担的全面降低提供重要依据.
Objective To assess the predictive value of the pan-immune-inflammation value(PIV)for all-cause and cause-specific mortality among individuals with depressive symptoms.Methods This prospective cohort study utilized data from the US National Health and Nutrition Examination Survey(NHANES,2005 to 2018)and the National Death Index(NDI,2005 to 2019).A total of 8 567 American patients with depression were enrolled.Participants were grouped by PIV quartiles(Q1,Q2,Q3,Q4)or dichotomized(low group,high group).Cox proportional hazards models were employed to estimate the association between PIV and all-cause,cardiovascular,and cancer mortality in patients with depression.Smooth curve fitting was applied to explore potential non-linear dose-response relationships.Threshold effect analysis was conducted to identify an inflection point,upon which a two-piecewise regression model was constructed.Kaplan-Meier survival curves were plotted to examine the association between PIV levels and survival status.Subgroup analyses were performed to evaluate the robustness of the observed associations.Results Cox regression showed that higher PIV levels were significantly associated with increased risks of all-cause mortality(HR=1.05,95%CI:1.04 to 1.07,P<0.001),cardiovascular mortality(HR=1.07,95%CI:1.05 to 1.10,P<0.001),and cancer mortality(HR=1.05,95%CI:1.01 to 1.08,P<0.001).Smooth curve fitting revealed a U-shaped relationship between PIV and all-cause mortality,with an inflection point at 80.97(P<0.05).Survival analysis indicated that when PIV>80.97,compared with the low group,the high group had increased all-cause mortality(HR=1.29,95%CI:1.12 to 1.48,P<0.001);compared with the Q1 group,the Q4 group also showed increased all-cause mortality(HR=1.53,95%CI:1.25 to 1.87,P<0.001).Subgroup analyses revealed stronger associations in specific populations:among females,for all-cause mortality(HR=1.08,95%CI:1.05 to 1.10,P=0.038)and cardiovascular mortality(HR=1.11,95%CI:1.07 to 1.16,P=0.031);In individuals with diabetes and those of other races(excluding Mexican American,other Hispanic,non-Hispanic White,and non-Hispanic Black),stronger associations were found between PIV and all-cause mortality(diabetes:HR=1.09,95%CI:1.06 to 1.10,P=0.023;other races:HR=1.22,95%CI:1.11 to 1.35,P=0.032)and cancer mortality(diabetes:HR=1.12,95%CI:1.06 to 1.18,P=0.006;other races:HR=2.00,95%CI:1.79 to 2.24,P=0.002).Conclusion Elevated PIV serves as an independent risk factor for multiple mortality outcomes in individuals with depressive symptoms.This study underscores the potential of PIV as a biomarker for predicting mortality risk.Utilizing PIV could aid in the early identification and targeted management of high-risk individuals,contributing to a comprehensive strategy for reducing the disease burden.
林博;鲁洺佑;袁杭滔;马学红;胡慧;郑入文
北京中医药大学第二临床医学院,北京南方医科大学第五临床医学院,广东广州北京中医药大学第二临床医学院,北京北京中医药大学东方医院针灸科,北京北京中医药大学东方医院针灸科,北京北京中医药大学东方医院针灸科,北京
医药卫生
泛免疫炎症值死亡率NHANES抑郁
pan-immune-inflammation valuemortalityNHANESdepression
《陆军军医大学学报》 2026 (5)
611-621,11
国家自然科学基金面上项目(82575223)北京中医药大学2023年度基本科研业务费(2023-JYB-JBZD-025) Supported by the General Program of National Natural Science Foundation of China(82575223)and the 2023 Basic Research Business Expense of Beijing University of Chinese Medicine(2023-JYB-JBZD-025)
评论